About Autonomix
Autonomix is a company based in The Woodlands (United States) founded in 2014 by Robert Schwartz and Landy Toth. Autonomix has raised $8.2 million across 3 funding rounds. The company has 11 employees as of March 31, 2024. Autonomix offers products and services including Nerve Sensing Catheter and Ablation System. Autonomix operates in a competitive market with competitors including Route 92 Medical, ReCor Medical, Ablative Solutions, Brattea and Kona Medical, among others.
- Headquarter The Woodlands, United States
- Employees 11 as on 31 Mar, 2024
- Founders Robert Schwartz, Landy Toth
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Autonomix Medical, Inc.
-
Annual Revenue
Not available
-
Net Profit
-$11.41 M (USD)26.03as on Mar 31, 2024
-
EBITDA
-$11.4 M (USD)-54.27as on Mar 31, 2024
-
Total Equity Funding
$8.2 M (USD)
in 3 rounds
-
Latest Funding Round
$2.4 M (USD), Series A
Jun 01, 2023
-
Investors
Not available
-
Employee Count
11
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Autonomix
Autonomix is a publicly listed company on the NASDAQ with ticker symbol AMIX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Autonomix
Autonomix offers a comprehensive portfolio of products and services, including Nerve Sensing Catheter and Ablation System.
Detects nerve signals for targeted ablation in pain management procedures.
Ablates overactive nerves to treat chronic pain and related conditions.
People of Autonomix
Unlock access to complete
Unlock access to complete
Funding Insights of Autonomix
Autonomix has successfully raised a total of $8.2M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $2.4 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Autonomix
Investment portfolio details for Autonomix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Autonomix
Detailed financials for Autonomix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Autonomix Comparisons
Peer comparison for Autonomix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Autonomix
Autonomix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Route 92 Medical, ReCor Medical, Ablative Solutions, Brattea and Kona Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Next-generation products for neurointerventional procedures are developed.
|
|
| Locked | Locked | Locked |
Ultrasound-based renal denervation is applied for hypertension treatment.
|
|
| Locked | Locked | Locked |
A catheter-based renal denervation system for hypertension treatment is developed.
|
|
| Locked | Locked | Locked |
Developer of a medical device for the treatment of hypertension
|
|
| Locked | Locked | Locked |
Provides ultrasound-based renal denervation solutions for hypertension treatment.
|
Detailed competitors of Autonomix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Autonomix
Complete news archive for Autonomix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Autonomix
Autonomix was founded in 2014.
Autonomix is headquartered in The Woodlands, United States. It is registered at The Woodlands, Texas, United States.
Lori Bisson is the current CEO of Autonomix.
Autonomix is a funded company, having raised a total of $8.2M across 3 funding rounds to date.
As of Mar 31, 2024, the latest employee count at Autonomix is 11.
Founded in 2014 and based in The Woodlands, United States, Autonomix operates in the neuromodulation sector. Proprietary microchips, hardware, and software are developed by the company for integration into catheters or similar devices. Electrophysiologic signal fidelity is improved, and data analysis is simplified through these technologies. Real-time neural monitoring and treatment solutions are provided for clinical applications in next-generation therapies.
Autonomix's top competitors include ReCor Medical, Route 92 Medical and Ablative Solutions.
Autonomix offers Nerve Sensing Catheter and Ablation System.
Yes, Autonomix is publicly traded on NASDAQ under the ticker symbol AMIX.
The ticker symbol of Autonomix is AMIX on NASDAQ.